According to their model, the absence of glucose leads to increased extracellular EP2 by stimulating PI3K/AKT/Cox2 signaling and downregulation of the EP2-degrading enzyme, 15-PGDH, via UPR/CHOP-mediated degradation to support tumor survival [99]. This evidence concerns the gene AKT1 and neoplasm.